Please assess the completion status of the following clinical trial:

Trial Title: A Pilot Study of the Feasibility of Chronic Cavernous Nerve Stimulation to Promote Regeneration and Erectile Function

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Scheduled for a robotic radical prostatectomy procedure with bilateral nerve sparing.~2. Sexually functional preoperatively as defined by a Sexual Health Inventory For Men (SHIM) score of greater than 21 at baseline off any phosphodiesterase 5 inhibitors.~3. Without erectile dysfunction treatment in the 12 months prior to radical prostatectomy.~4. Willing to stop phosphodiesterase 5 inhibitor that has only been started prophylactically to promote penile rehabilitation after prostatectomy.~5. Age 40 to 80 years of age.~6. Stable on all medications for at least 6 weeks prior to completing baseline measures and be willing to remain on those medications with no dose adjustments expected for 6 weeks post-implantation.~7. An appropriate candidate for the surgical procedure required for this study.~8. Willing and able to comply with all study related procedures and visits, and making accurate daily entries into a diary for approximately 6 weeks post radical prostatectomy (lead stimulation phase).~9. Capable of reading and understanding patient information materials and giving written informed consent.~Exclusion Criteria:~1. Have been diagnosed with vascular insufficiency to any pelvic blood vessels.~2. Have prior surgical implantation of penile prosthesis, or other prior major pelvic surgery.~3. History of significant pelvic trauma.~4. Are current substance abusers including illicit drugs or use narcotics more than 15 days/month.~5. Have a significant psychiatric disorder or under current treatment with antipsychotic or antidepressive medications.~6. Have previously not tolerated an implanted medical device and subsequently required explant of the device for any reason other than device malfunction.~7. Have a condition currently requiring or likely to require the use of MRI or diathermy.~8. Currently have an active implantable device.~9. Have participated in any drug or device trial in the last 4 weeks or plan to participate in any other drug or device study during the next 24 months.~10. Have metabolic or immunodeficiency disorders related to recurrent infections, specifically including but not limited to diabetes mellitus, HIV, disorders requiring chronic or high dose corticosteroids, or connective tissue disorders.~11. Have Peyronies disease.~12. Subject possesses any other characteristics that, per the investigator's judgment, deems them unsuitable (eg increases risk, impairs data collection, etc) for the procedure/study.

- Gender: MALE
- Minimum Age: 40 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Nerve Stimulation (Type: EXPERIMENTAL): Placement and stimulation of implantable neurostimulation device/leads post radical robotic prostatectomy

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues